Although our results indicate that the capacity of Sox3 to hinder differentiation is conserved between glioma cells and NSCs, further studies will be necessary to explain the exact role of Oct4, Nanog and Klf4 in gliomas. The gene discussed is SOX3; the disease is central nervous system cancer.